DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5

Imperial Brands Warns Of Lower Annual Profit Due To US FDA Ban

By Steve Wynne-Jones
Share this article
Imperial Brands Warns Of Lower Annual Profit Due To US FDA Ban

Tobacco group Imperial Brands said that it expects full-year adjusted earnings to be slightly lower than last year due to a US regulatory ban on some flavours of cartridge-based vapour devices and weaker consumer demand.

The warning comes on the heels of Stefan Bomhard's appointment as the Chief Executive Officer of the FTSE 100-listed group.

Imperial Brands said the ban by the U.S. Food and Drug Administration (FDA), which comes into effect this week, has led to a write-down of flavoured inventory, which would have a £45 million (€53.2 million) impact on first-half adjusted operating profit.

Tobacco Trading

'Tobacco trading remains in line with expectations, with a weighting to the second half as previously guided,' the firm made in a statement to coincide with its AGM.

'However, following the US FDA’s ban on certain flavours of cartridge-based vapour devices and weaker than expected consumer demand for vapour, we now expect constant currency full year group net revenue to be at a similar level to last year and adjusted earnings per share to be slightly lower than last year.'

News by Reuters, edited by ESM. Click subscribe to sign up to ESM: European Supermarket Magazine.

ADVERTISEMENT
Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.